The hypotheses surrounding the experiment were that the dobutamine would produce tachycardia and vasodilation and fail to improve the microcirculation of patients with septic shock.
The results of the double-blind test showed that dobutamine increased heart rate, cardiac index and stroke volume index, which increased in 52 percent of the patients. Patient blood pressure remained unchanged but systemic vascular resistance decreased.
More Articles on Anesthesia:
Compounding Pharmacies May Relieve Drug Shortage for Anesthesiologists
Checklist for F1RSTUse Platform Released by Anesthesia Business Consultants
Accutron’s Ultra PC Flowmeter Sedation System Recalled by FDA
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
